Video Library


 

Webinar: The new standard in NGS-based myeloid mutation detection

  • Published on Monday, November 13, 2017
In this webinar, Massachusetts General Hospital pathologist Long Phi Le, MD, PhD, will discuss how updates to the assay and software provide better coverage, lower limits of detection, high-resolution CNV detection and lightning-fast analysis. Brent Lutz, Software Product Manager at ArcherDX, will introduce Dr. Le, as well as review the latest improvements in Archer Analysis.

 

Archer Immunoverse TCR and BCR sequencing kits

  • Published on Friday, July 7, 2017
Archer® Immunoverse™ kits are targeted NGS assays to characterize the human immune repertoire from RNA input. Powered by Anchored Multiplex PCR (AMP™), the lyophilized kits uniquely tag and amplify V(D)J rearrangements for sequencing on Illumina® platforms.

 

Get less noise and more signficiance from liquid biopsies with Archer® Reveal ctDNA™. Learn more today.

Archer Reveal ctDNA 28

  • Published on Monday, February 13, 2017
The Archer® Reveal ctDNA™ 28 Kit for Illumina® is an advanced and user-friendly solution for targeted next generation sequencing (NGS) of circulating cell-free tumor DNA (ccfDNA/cfDNA/ctDNA) from 28 genes commonly found mutated in solid tumor type cancers.

 

Video: Detecting meaningful mutations from liquid biopsies by Anchored Multiplex PCR

  • Published on Monday, January 23, 2017
In this webinar, Josh Stahl and Jonathan Doose from ArcherDX will describe AMP-based ctDNA library preparation method

 

From enhanced variant calling to immune repertoire analysis: Greater assay design and analytics with Archer software updates

  • Published on Friday, January 13, 2017
In this webinar, Brent Lutz, Product Manager of Software, and Doug Wendel, Senior Director of Software, will detail new Assay Designer and Analysis features designed to leverage and maximize the unique power of the patented Anchored Multiplex PCR (AMP™) target enrichment chemistry used in Archer NGS assays.

 

Clinical Tumor Sequencing: Applications and considerations for targeted sequencing using Anchored Multiplex PCR

  • Published on Friday, November 4, 2016
In this webinar, Dr. Patrick Hurban, Senior Director and Global Head of Genomic Development & Esoteric Assays at Q2 Solutions reviews multiple applications of AMP-based NGS performed in a global CRO, discussing assay suitability and performance for multiple disease and mutation types.

 

Clinical offerings at the Jackson Laboratory: Validation of the Archer® FusionPlex® Solid Tumor Panel

  • Published on Thursday, October 6, 2016
In this webinar Dr. Honey V Reddi explores the JAX® clinical genomics program with a look into the validation of the Archer FusionPlex solid tumor kit for Next Generation Sequencing (NGS)

 

Characterizing Hematologic Driver Mutations With Archer® Blood Cancer Assays

  • Published on Friday, August 19, 2016
Dr. Laura Griffin and Darius Fugere discuss the different hematological disease states, their biology, driver mutations and current detection methods. They also share data demonstrating how Archer Blood Cancer NGS Assays enable detection of all driver mutation types.

 

FLT3-ITD Detection With Archer® Blood Cancer Assays

  • Published on Friday, August 19, 2016
The molecular landscape of leukemia and lymphoma has expanded exponentially in the last two decades, and the complexity and scope of biomarkers makes molecular analysis difficult for any single approach. Archer FusionPlex and VariantPlex assays are powered by Anchored Multiplex PCR (AMP™) target enrichment chemistry to detect multiple mutation types and gene expression profiling in a single sample.

 

Archer® Starter Kits - The 80's PCR guy

  • Published on Friday, July 15, 2016
RADICAL! Hold on for a crazy blast-to-the past with 80's PCR guy. His data is simple and he just misses so much! Never miss a fusion, mutation, or expression imbalance again with Archer FusionPlex and VariantPlex Assays. get the best out of your NGS data, not your hair gel!

 

Next Generation Sequencing Applications and Sample Prep Workflow Improvements

  • Published on Wednesday, May 18, 2016
Josh Stahl, Chief Scientific Officer and General Manager at ArcherDX, discusses the challenges of detecting gene fusions from FFPE samples, the advantages of using Archer™ FusionPlex™ assays and how high-quality nucleic acid purification results in longer reads and higher-complexity libraries.

 

Archer Analysis Unlimited

  • Published on Tuesday, May 17, 2016
Analysis Unlimited is a private, cloud-based instance of the Archer Analysis bioinformatics suite efficiently configured to handle hundreds of samples simultaneously. Get the fastest analysis times without any expensive hardware or associated maintenance with Analysis Unlimited.

 

Archer™ Analysis - Processing Time

  • Published on Tuesday, April 5, 2016
Doug Wendel, Senior director of software at Archer, explains the differences between the four different installations of Archer Analysis. You can now get the most out of your bioinformatic software tools and only pay for as little or as much as you need. Take your fusion and mutation discovery to the next level with Archer Analysis.

 

Archer™ Analysis - View and filter variants

  • Published on Tuesday, April 5, 2016
In Analysis 4.0 it's now easier than ever to view and filter variants. In this video, Violet Roskens demonstrates how to create and save filter sets, organize bioinformatic data, and export and view your data in external applications.

 

Archer Analysis 4.0 Highlights

  • Published on Monday, January 25, 2016
Learn about the new feature in Archer Analysis 4.0, including RNA expression visualization, enhanced Quiver™ fusion database integration, and new optimizations in security and stability.

 

What's new in Archer Analysis 4.0

  • Published on Friday, January 15, 2016
Doug Wendel overviews the highlights of the latest software release, Archer Analysis 4.0, introducing new features such as: fusion visualization, RNA abundance and imbalance for fusions, DNA variant filling, and private cloud options and auto-scaling.

 

Why RNA is better for fusion detection

  • Published on Friday, November 13, 2015
Why do Archer FusionPlex™ assays use RNA instead of DNA for input material? It all comes down to biological relevance, cost, and turn-around time. See why RNA is better for fusion detection than DNA-based hybrid capture techniques.

 

AMP is better: Strand Specificity

  • Published on Thursday, August 13, 2015
See how Anchored Multiplex PCR (AMP™) chemistry is better than traditional opposing primer-based enrichment, because strand-specific priming allows you to identify and correct for deamination events that would otherwise lease to false-positive results.

 

Comprehensive Tumor Profiling

  • Published on Wednesday, July 29, 2015
Learn how using Archer™ FusionPlex™ RNA assays and VariantPlex™ DNA assays in parallel makes it possible to generate comprehensive target-enriched libraries for next-generation sequencing to detect clinically relevant fusions, CNVs, SNVs and indels.

 

FusionPlex Anchored Multiplex PCR (AMP) Chemistry

  • Published on Wednesday, July 29, 2015
Learn how the FusionPlex system utilizes Anchored Multiplex PCR chemistry to create target enriched RNA libraries for next-generation sequencing.

 

VariantPlex Anchored Multiplex PCR (AMP) Chemistry

  • Published on Wednesday, July 29, 2015
Learn how the Archer VariantPlex system uses Anchored Multiplex PCR, which utilizes a combination of gene specific primers and half-functional universal adapters to create target enriched DNA libraries for next generation sequencing.

 

VariantPlex Workflow

  • Published on Monday, July 20, 2015
Learn the proper steps and processes for targeted DNA library preparation using the Archer VariantPlex system. By using Anchored Multiplex PCR and a modular design, you can rapidly create target enriched libraries from genomic DNA in just a few hours. After sequencing, analyze your data in Archer Analysis to identify CNVs, SNVs, and indels.

 

Learn more about Archer® FusionPlex® NGS assays that use Anchored Multiplex PCR (AMP™) chemistry to detect novel fusions.

AMP is better for novel gene fusion detection

  • Published on Friday, July 17, 2015
Anchored Multiplex PCR enables the detection of targets of interest, including any known or novel fusion partners by using target-specific primers uni-directional primers, along with reverse primers, that hybridize to the sequencing adapter that is ligated to each fragment prior to amplification.

 

Archer Custom Panels used by Baby Genes™ CLIA-certified lab

  • Published on Tuesday, June 30, 2015
BabyGenes, Inc., is a Colorado-based company that provides quick supplemental next-generation sequencing (NGS)-based newborn screening. In this video, Rich Sjogren, CEO, and Angie Purvis, PhD, Associate Laboratory Director, discuss state-mandated newborn screening and the NGS-based service that Baby Genes provides, as well as why Archer Custom Panels were the right choice for their panel needs.

 

Beyond Fusions: Comprehensive NGS-based Analysis of Solid Tumors using Anchored Multiplex PCR (AMP™)

  • Published on Tuesday, June 23, 2015
Josh Stahl, Vice-President of R&D and Scientific Operations, discusses AMP Chemistry and how it is best suited for DNA-based mutation detection, Archer VariantPlex detection of CNVs, and how combining FusionPlex and VariantPlex maximizes mutation detection

 

Archer Analysis 3.2: Purpose Built Software Tools for Tumor Sequencing

  • Published on Tuesday, June 23, 2015
Thon deBoer, PhD, discusses updates to Archer Analysis 3.2 which now supports Archer VariantPlex DNA assays, germline mutation calling, a greater integration with the Archer Quiver™ Fusion Database and customizable, printable analysis reports.

 

The Archer VariantPlex Solid Tumor NGS Panel

  • Published on Thursday, July 2, 2015
The VariantPlex Solid Tumor Panel is a targeted DNA sequencing assay that simultaneously detects and characterizes CNVs, SNPs and indels in 67 genes associated with solid tumors.

 

Brady Culver Webinar - Development and implementation of the Archer FusionPlex Solid Tumor Panel

  • Published on Friday, May 1, 2015
Brady Culver, PhD describes the challenges of gene fusions discovery in solid tumors and his process for developing and characterizing a comprehensive NGS panel to assess translocations in these tumor types.

 

Archer Analysis - Difference between re-running and cloning a job

  • Published on Monday, April 6, 2015
What's the difference between re-running a job and cloning a job in Archer Analysis? Field Application Specialist Ashleigh Teator, Ph.D., knows, and we got her to spill the beans

 

Archer Analysis - Starting a new job

  • Published on Monday, April 6, 2015
Want to see how to start a new Archer Analysis job? Field Application Specialist Ashleigh Teator, Ph.D., walks you through the process.

 

Value of Molecular Barcodes for NGS error correction

  • Published on Thursday, March 12, 2015
Learn how molecular barcodes (MBCs) can positively impact the quality of your sequencing data

 

Archer Molecular Barcode Adapters

  • Published on Thursday, March 12, 2015
Archer Anchored Multiplex PCR (AMP) technology utilizes Molecular Barcode (MBC) Adapters for error correction, sample identification, de duplication, and advanced analysis in targeted sequencing NGS applications

 

Archer Analysis - JBrowse walkthrough

  • Published on
Archer Analysis provides the ability to visualize your NGS data directly in your browser window using the open-source tool JBrowse. With JBrowse you can access information to your targeted sequencing data right down to single-base levels, and give your fusion data greater clarity.

 

Archer FusionPlex Workflow

  • Published on Tuesday, March 10, 2015
See how easy Archer FusionPlex assays are in this detailed workflow and protocol video.

 

Archer FusionPlex ALK, RET, ROS1 v2 Panel Overview

  • Published on Tuesday, March 10, 2015
The Archer FusionPlex ALK, RET, ROS1 v2 panel generates targeted next-generation sequencing libraries when used in conjunction with Archer Molecular Barcode Adapters and Universal RNA Reagent Kit

 

Find our fit.
Get true NGS assay customization with Archer® Assay Designer. Learn more today.

Archer FusionPlex Custom Panels Overview

  • Published on Tuesday, March 10, 2015
Use the Archer Assay Designer to create FusionPlex custom panels to detect and characterize specific gene fusions in your samples by next-generation sequencing

 

Agencourt FormaPure FFPE Sample Preparation Protocol

  • Published on Wednesday, February 11, 2015
Learn about how to use the FormaPure kit to purify nucleic acid from formalin-fixed paraffin-embedded tissues to prepare target-enriched libraries using Archer NGS assays.

 

Archer FusionPlex Sarcoma Panel Video

  • Published on Wednesday, January 21, 2015
Detect and characterize sarcoma-associated fusion events by next-generation sequencing (NGS) using this panel that targets 26 genes and their known and unknown fusion partners.

 

Anchored Multiplex PCR chemistry

  • Published on Wednesday, January 21, 2015
Anchored Multiplex PCR (AMP) uses gene-specific primers and half-functional universal adapters to generate DNA libraries that are enriched for specific targets and any unknown fusion partners, which can then be detected by next-generation sequencing.

 

The value of richer NGS data sets using Anchored Multiplex PCR

  • Published on Wednesday, January 21, 2015
In this webinar, Dr. Kudlow discusses catalog and custom Archer™ products built upon the AMP™ technology and reviews the scope and power of the data generated with this technology. Anchored Multiplex PCR (AMP™) is a novel technology to prepare target-enriched libraries from both RNA and DNA inputs for gene rearrangement detection and characterization by next-generation sequencing (NGS). AMP™ enriches for target fragments by PCR using an adapter that is ligated at random locations and target-specific primers. This method of library preparation confers numerous advantages over amplicon-based library construction in both the downstream data analysis as well as the scalability of translocation detection assays.

 

NGS-based Sarcoma Fusion Detection: Breakthroughs in Clinical Research

  • Published on Wednesday, January 21, 2015
Alexander Lazar, MD, PhD, Director of both the Sarcoma & Melanoma Molecular Diagnostics and the Soft Tissue & Bone Fellowship Training Program at MD Anderson Cancer Center, discusses sarcoma classifications and how he is using next-generation sequencing to detect gene fusions and classify cancer types. This webinar was recorded on September 10, 2014.

How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2017 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.